Show simple item record

Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis

dc.contributor.authorStrollo, Rocky
dc.contributor.authorPonchel, Frederique
dc.contributor.authorMalmström, V
dc.contributor.authorRizzo, P
dc.contributor.authorBombardieri, M
dc.contributor.authorWenham, CY
dc.contributor.authorLandy, R
dc.contributor.authorPerret, D
dc.contributor.authorWatt, F
dc.contributor.authorCorrigall, VM
dc.contributor.authorWinyard, Paul G.
dc.contributor.authorPozzilli, P
dc.contributor.authorConaghan, PG
dc.contributor.authorPanayi, GS
dc.contributor.authorKlareskog, L
dc.contributor.authorEmery, Paul
dc.contributor.authorNissim, Ahuva
dc.date.accessioned2013-11-14T14:14:41Z
dc.date.issued2013-04-10
dc.description.abstractType II collagen (CII) posttranslationally modified by reactive oxygen species (ROS-CII) that are present in the inflamed joint is an autoantigen in rheumatoid arthritis (RA). The aim of this study was to investigate the potential use of anti-ROS-CII autoantibodies as a biomarker of RA.en_GB
dc.identifier.citationVol. 65, Issue 7, pp. 1702 - 1712en_GB
dc.identifier.doi10.1002/art.37964
dc.identifier.urihttp://hdl.handle.net/10871/13950
dc.language.isoenen_GB
dc.publisherWiley-Blackwellen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/23575908en_GB
dc.rights.embargoreasonPublisher's policyen_GB
dc.titleAutoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritisen_GB
dc.typeArticleen_GB
dc.identifier.issn0004-3591
dc.identifier.journalArthritis and Rheumatismen_GB


Files in this item

Name:
Strollo et al AR 2013 accepted ...
Size:
910.0Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record